BRIEF published on 02/19/2025 at 15:29, 1 year 3 months ago The Vanguard Group Discloses Stake in PRS REIT plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group PRS REIT
BRIEF published on 02/19/2025 at 15:29, 1 year 3 months ago Le groupe Vanguard révèle sa participation dans PRS REIT plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Valeurs Mobilières PRS REIT
BRIEF published on 02/19/2025 at 15:28, 1 year 3 months ago The Vanguard Group Discloses Stakes in International Distribution Services plc The Vanguard Group Takeover Code Securities Disclosure Share Transactions International Distribution Services
BRIEF published on 02/19/2025 at 15:28, 1 year 3 months ago Le groupe Vanguard dévoile ses participations dans International Distribution Services plc Code De Prise De Contrôle Le Groupe Vanguard Services De Distribution Internationale Transactions Sur Actions Divulgation Des Valeurs Mobilières
BRIEF published on 02/19/2025 at 15:27, 1 year 3 months ago The Vanguard Group's Disclosure on Hargreaves Lansdown Takeover Code Securities Disclosure Vanguard Group Shareholding Hargreaves Lansdown
BRIEF published on 02/19/2025 at 15:27, 1 year 3 months ago Divulgation du groupe Vanguard sur Hargreaves Lansdown Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Hargreaves Lansdown
BRIEF published on 02/19/2025 at 15:26, 1 year 3 months ago The Vanguard Group Discloses Position in Spirent Communications Form 8.3 The Vanguard Group Takeover Code Stock Disclosure Spirent Communications
BRIEF published on 02/19/2025 at 15:26, 1 year 3 months ago Le groupe Vanguard révèle sa position dans Spirent Communications Code De Prise De Contrôle Le Groupe Vanguard Formulaire 8.3 Spirent Communications Divulgation Des Stocks
BRIEF published on 02/19/2025 at 15:05, 1 year 3 months ago Jaguar Health Advances Crofelemer Study in Europe Crofelemer Clinical Trials Jaguar Health Orphan-Drug Designation Rare Diseases
BRIEF published on 02/19/2025 at 15:05, 1 year 3 months ago Jaguar Health fait progresser l'étude sur le Crofelemer en Europe Crofelemer Essais Cliniques Désignation De Médicament Orphelin Maladies Rares Santé Jaguar
Published on 05/21/2026 at 23:00, 8 hours 51 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 8 hours 51 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 8 hours 51 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 9 hours 36 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 07:00, 51 minutes ago Curatis Holding AG announces CHF 3.0 million private placement with strategic investor
Published on 05/22/2026 at 07:00, 51 minutes ago Interim Management Statement for the first four months of 2026*
Published on 05/22/2026 at 07:00, 51 minutes ago Edisun Power Europe SA communique la décision de la Commission des offres publiques d'acquisition
Published on 05/22/2026 at 06:35, 1 hour 16 minutes ago VARON Highlights Respiratory Wellness and Active Aging Ahead of Pentecost in Germany
Published on 05/22/2026 at 06:30, 1 hour 21 minutes ago Interroll publishes Sustainability Report 2025
Published on 05/21/2026 at 17:45, 14 hours 6 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 14 hours 6 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 15 hours 15 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
